Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
SCIE--->UNDERVALUED !SCIE SpectraScience Inc.
-The Company’s lead platform—the WavSTAT® Optical Biopsy System—is in the final stages of a multicenter, 1,200-patient European study and is poised to commence sales in Europe and potentially Saudi Arabia in 2016 and new markets in China and India during 2017. The current WavSTAT4 product is initially targeted to the colorectal cancer screening market where recent colonoscopy guidelines have created opportunities for new, improved diagnostic technologies.
-Up to 80% of colorectal biopsies performed are estimated to be identified as normal, non-cancerous tissue. Replacing these invasive physical biopsies with an optical biopsy, as SpectraScience's WavSTAT4 does, reduces risks to patients and may lead to a healthcare cost savings of over $1 billion in the U.S. alone.
-WavSTAT4 has been designed for ease of integration into the current standard of care. It entails essentially the same process as how physicians screen for cancer today, and is compatible with existing endoscopes. SpectraScience merely adds a layer of diagnostic interpretation and confidence by notifying physicians that, at a particular tissue location, they do not need to take a physical biopsy that they otherwise might have performed.
-Tissue that WavSTAT4 finds to be precancerous or cancerous returns a red “suspect” icon. Unlike the traditional method of visual inspection, there is no ambiguity to the result and no need for physician interpretation.
SpectraScience is further evaluating the potential of its technology in an array of additional indications and using a combination of next-generation, light-based technologies. Clinical results have suggested potential for WavSTAT4 in bladder cancer as well as in other oncology areas. SpectraScience in particular views the esophageal screening market as an opportunity, as endoscopes are the typical diagnostic tool of choice for both colorectal and esophageal screening.
-SpectraScience’s patent portfolio in the field of optical methods to detect cancer, cancer precursors, and tissue abnormalities includes 34 U.S. utility patents, seven U.S. design patents, 25 foreign counterpart patents, and an exclusive license to the Massachusetts General Hospital’s optical forceps patent.
-SpectraScience Inc has signed a distribution agreement with Advanced Medical German Co. (AMG) in Kuwait to be its exclusive distributor in the Middle East in july 2016
Or if there will come in a big amount of volume inside this stock.
For the moment its too calm here.We need new eyes on this one!
Why to buy this --->UNDERVALUED !SCIE SpectraScience Inc.
-The Company’s lead platform—the WavSTAT® Optical Biopsy System—is in the final stages of a multicenter, 1,200-patient European study and is poised to commence sales in Europe and potentially Saudi Arabia in 2016 and new markets in China and India during 2017. The current WavSTAT4 product is initially targeted to the colorectal cancer screening market where recent colonoscopy guidelines have created opportunities for new, improved diagnostic technologies.
-Up to 80% of colorectal biopsies performed are estimated to be identified as normal, non-cancerous tissue. Replacing these invasive physical biopsies with an optical biopsy, as SpectraScience's WavSTAT4 does, reduces risks to patients and may lead to a healthcare cost savings of over $1 billion in the U.S. alone.
-WavSTAT4 has been designed for ease of integration into the current standard of care. It entails essentially the same process as how physicians screen for cancer today, and is compatible with existing endoscopes. SpectraScience merely adds a layer of diagnostic interpretation and confidence by notifying physicians that, at a particular tissue location, they do not need to take a physical biopsy that they otherwise might have performed.
-Tissue that WavSTAT4 finds to be precancerous or cancerous returns a red “suspect” icon. Unlike the traditional method of visual inspection, there is no ambiguity to the result and no need for physician interpretation.
SpectraScience is further evaluating the potential of its technology in an array of additional indications and using a combination of next-generation, light-based technologies. Clinical results have suggested potential for WavSTAT4 in bladder cancer as well as in other oncology areas. SpectraScience in particular views the esophageal screening market as an opportunity, as endoscopes are the typical diagnostic tool of choice for both colorectal and esophageal screening.
-SpectraScience’s patent portfolio in the field of optical methods to detect cancer, cancer precursors, and tissue abnormalities includes 34 U.S. utility patents, seven U.S. design patents, 25 foreign counterpart patents, and an exclusive license to the Massachusetts General Hospital’s optical forceps patent.
-SpectraScience Inc has signed a distribution agreement with Advanced Medical German Co. (AMG) in Kuwait to be its exclusive distributor in the Middle East in july 2016
The shareholders could be caught up in a corporate bankruptcy and accounting scandal when they sell this one too early=its called bagholders profit ,no?
I totally agree!
To rise 100% today,correct or no?
Good idea but we have too less followers.
Maybe better to bring it on the Breakout Boards tomorrow?
And ask your question again
Can you put 5 zero's tomorrow?
Yes,I understood
Like a sexy uncover agent
Yes and the stock went up 100% LOL
MM's with VNDM are controlling it here!If its going down too much VNDM moves up,if it wants to break 17-18 VNDM puts a wall.We have seen this games going on for 2-3 months going.
We need a massive whale coming in or massive buying and this will run huge!VNDM hasn't got much shares,already saw this.
We need buying volume and we take off!
I not agree totally,the company almost every 3-4 months comes with news or update!I have seen companies here on Ihub with much more action and they didn't have news or update for more then 1 year!
The big problem with BMIC is where he wanna bring this, with his action?We came from 0.0024 and we almost back where it started.
It took 2 months to break 0.0010$!People who was here can confirm this.
He came back,why?Because the stock went too high?Why he didn't let the stock run!
Company buying back shares??for a big acquisition?
Nobody not really attacking him,(makes no sense btw)and he just waiting or ticking down.
Hope to see news in this months or at least an update!
Its as thin as toiletpaper here,VNDM not even have millions,just a few and its moving up.
Can you imagine how the stock could move with a 60 million volume day?
This stock has a huge potential but its unknown on IHUB!
We need buyers!New viewers,whales,investors.Breakout Boards.People who believe in this company,its too calm here!
13's are up!! 1.500.000 in retail.
With some buying pressure this can be fast in the 20's.
People just don't know this stock!We are not a scam,but we have a PPS like a scam a the moment!MEGA UNDERVALUED!!
Yes like my bull,LOL It can get wild
105000 shares left at 12 and 13 is up!
Nice to see NECA$$ back!!
We just came on the Breakout Boards!
A lot of eyes on this one!Its not going to stay long here!
Good idea!!
If you can catch 3's be happy.If the news and updates hit your 3's will be golden!
I not agree. loading zone was 3,there is a 420million wall of 2's and only 120million wall of 4's
If you wanna miss to 400%-1000% ride up!Wait for 2's
4's is up,no 2's!
To load 2 and 1?LOL
Just undervalued here!
I agree preparing for a big run here!
Bid growing 30+MILLION
VNDM controlling here,once he moved up this will go up!
Its just undervalued here,loading between .0011-0.0017 is going on here!Once update comes it will fly like a rocket!
We have to know the exact float,the O/S not really matters.
The lower the float,the faster we go up,even when the O/S is very high.
The 290 million is already calculated in the PPS now,so stop blaiming the CEO if you even don't know for what he used the extra shares.We can't prove nothing.
I don't see this going much lower!From here we going back up!
With news for sure!